Saba Capital Management’s Isleworth Healthcare Acquisition Corporation Common stock ISLE Stock Holding History

Saba Capital Management’s Portfolio ISLE Stock Details ISLE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-777,547	Closed	-$7.74M	–	1193
2022 Q2	$7.74M	Hold	777,547	–	–	0.09%	410
2022 Q1	$7.7M	Buy	777,547 +314,491	+68%	+$3.1M	0.11%	324
2021 Q4	$4.56M	Buy	463,056 +375,734	+430%	+$3.69M	0.07%	391
2021 Q3	$858K	Buy	87,322 +6,893	+9%	+$67.2K	0.02%	446
2021 Q2	$788K	Buy	80,429 +22,388	+39%	+$219K	0.02%	377
2021 Q1	$562K	Buy	+58,041	New	+$561K	0.02%	330

Saba Capital Management's ISLE Position: Q3 2022 in Review

Saba Capital Management sold out of Isleworth Healthcare Acquisition Corporation Common stock (ISLE) in Q3 2022, closing a stake of 777,547 shares — an estimated $7.74M sold.

Saba Capital Management first reported a position in ISLE in Q1 2021 and held it in 6 quarters. The position peaked at $7.74M in Q2 2022. 0 funds tracked by Wall St. Rank hold ISLE as of Q3 2022.

Saba Capital Management reported no remaining Isleworth Healthcare Acquisition Corporation Common stock position as of Q3 2022 after selling out during the quarter.
Saba Capital Management sold 777,547 Isleworth Healthcare Acquisition Corporation Common stock shares in Q3 2022, an estimated $7.74M.
Saba Capital Management first reported a position in Isleworth Healthcare Acquisition Corporation Common stock in Q1 2021 and held it in 6 quarters.
Saba Capital Management's Isleworth Healthcare Acquisition Corporation Common stock position peaked at $7.74M in Q2 2022.
0 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Common stock as of Q3 2022.

Based on Saba Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.